Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
March-2015 Volume 35 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2015 Volume 35 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB

  • Authors:
    • Lei Qiu
    • Guojian Yin
    • Li Cheng
    • Yuting Fan
    • Wenqin Xiao
    • Ge Yu
    • Miao Xing
    • Rongrong Jia
    • Ruiqing Sun
    • Xiuying Ma
    • Guoyong Hu
    • Xingpeng Wang
    • Maochun Tang
    • Yan Zhao
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China, Department of Gastroenterology, Shanghai First People's Hospital, Shanghai JiaoTong University, Shanghai 200080, P.R. China
    Copyright: © Qiu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 625-636
    |
    Published online on: January 16, 2015
       https://doi.org/10.3892/ijmm.2015.2070
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

This study aimed to investigate the effects of astragaloside IV (AS-IV; 3-O-β-D-xylopyranosyl-6-O‑β-D-glucopyranosylcycloastragenol), which has been reported to have comprehensive pharmacological functions, on sodium taurocholate (NaTc)/L-arginine (L-Arg)-induced acute pancreatitis (AP) in rats in vivo and in rat pancreatic acinar cells in vitro. NaTc-induced experimental AP was induced in rats by injecting 4% NaTc (0.1 ml/100 g) in the retrograde direction of the biliopancreatic duct. L-Arg-induced experimental AP was induced in rats by 2 intraperitoneal injections of 20% L-arg (3 g/kg), with an interval of 1 h between the injections. The rats were pre-treated AS-IV (50 mg/kg) or the vehicle (DMSO) 2 h prior to the induction of AP. Enzyme-linked immunosorbent assay, H&E staining, myeloperoxidase (MPO) activity, reverse transcription-quantitative PCR, western blot analysis and immunohistochemistry were used to evaluate the effects of AS-IV on AP. The results revealed that treatment with AS-IV significantly reduced serum amylase and lipase levels, pancreatic pathological alterations, the secretion of pro-inflammatory cytokines, MPO activity, and the protein expression of nuclear factor-κB (NF-κB) in vivo. Moreover, pre-treatment with AS-IV significantly increased the expression levels of manganese superoxide dismutase and cuprum/zinc superoxide dismutase. In the in vitro experiment, treatment of the cells with AS-IV aslo reduced rat pancreatic acinar cell necrosis and nuclear NF-κB activity, and enhanced the protein expression of superoxide dismutase. In conclusion, this study indicates that the protective effects of AS-IV on experimental AP in rats may be closely related to the inhibition of NF-κB. In addition, our results indicate that AS-IV may exert potential antioxidant effects on AP. Therefore, AS-IV may be an effective therapeutic agent for AP.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Long J, Song N, Liu XP, Guo KJ and Guo RX: Nuclear factor-kappaB activation on the reactive oxygen species in acute necrotizing pancreatitic rats. World J Gastroenterol. 11:4277–4280. 2005.PubMed/NCBI

2 

Pandol SJ, Saluja AK, Imrie CW and Banks PA: Acute pancreatitis: bench to the bedside. Gastroenterology. 132:1127–1151. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Sweiry JH and Mann GE: Role of oxidative stress in the pathogenesis of acute pancreatitis. Scand J Gastroenterol Suppl. 219:10–15. 1996. View Article : Google Scholar : PubMed/NCBI

4 

Gukovskaya AS, Gukovsky I, Zaninovic V, et al: Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest. 100:1853–1862. 1997. View Article : Google Scholar : PubMed/NCBI

5 

Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP and Slavin J: Inflammatory mediators in acute pancreatitis. J Pathol. 190:117–125. 2000. View Article : Google Scholar : PubMed/NCBI

6 

Norman J: The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 175:76–83. 1998. View Article : Google Scholar : PubMed/NCBI

7 

Makhija R and Kingsnorth AN: Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg. 9:401–410. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Zyromski N and Murr MM: Evolving concepts in the pathophysiology of acute pancreatitis. Surgery. 133:235–237. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Zhang XP, Wang L and Zhou YF: The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge. Dig Dis Sci. 53:297–306. 2008. View Article : Google Scholar

10 

Mayer J, Rau B, Gansauge F and Beger HG: Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 47:546–552. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Malleo G, Mazzon E, Siriwardena AK and Cuzzocrea S: Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock. 28:130–140. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Kim H, Seo JY and Kim KH: NF-kappaB and cytokines in pancreatic acinar cells. J Korean Med Sci. 15(Suppl): S53–S54. 2000. View Article : Google Scholar : PubMed/NCBI

13 

Gukovsky I and Gukovskaya A: Nuclear factor-kappaB in pancreatitis: Jack-of-all-trades, but which one is more important? Gastroenterology. 144:26–29. 2013. View Article : Google Scholar

14 

Algül H, Tando Y, Schneider G, Weidenbach H, Adler G and Schmid RM: Acute experimental pancreatitis and NF-kappaB/Rel activation. Pancreatology. 2:503–509. 2002. View Article : Google Scholar : PubMed/NCBI

15 

Schoenberg MH, Büchler M and Beger HG: The role of oxygen radicals in experimental acute pancreatitis. Free Radic Biol Med. 12:515–522. 1992. View Article : Google Scholar : PubMed/NCBI

16 

Schoenberg MH, Birk D and Beger HG: Oxidative stress in acute and chronic pancreatitis. Am J Clin Nutr. 62(Suppl 6): 1306S–1314S. 1995.PubMed/NCBI

17 

Li M, Yu L, She T, et al: Astragaloside IV attenuates Toll-like receptor 4 expression via NF-kappaB pathway under high glucose condition in mesenchymal stem cells. Eur J Pharmacol. 696:203–209. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Ren S, Zhang H, Mu Y, Sun M and Liu P: Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med. 33:413–416. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Zhang WJ, Hufnagl P, Binder BR and Wojta J: Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost. 90:904–914. 2003.PubMed/NCBI

20 

Yang Q, Lu JT, Zhou AW, Wang B, He GW and Chen MZ: Antinociceptive effect of astragalosides and its mechanism of action. Acta Pharmacol Sin. 22:809–812. 2001.PubMed/NCBI

21 

Li M, Qu YZ, Zhao ZW, et al: Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem Int. 60:458–465. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Du Q, Chen Z, Zhou LF, Zhang Q, Huang M and Yin KS: Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma. Can J Physiol Pharmacol. 86:449–457. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Ko JK, Lam FY and Cheung AP: Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 11:5787–5794. 2005.PubMed/NCBI

24 

Hu G, Shen J, Cheng L, et al: Reg4 protects against acinar cell necrosis in experimental pancreatitis. Gut. 60:820–828. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Shi C, Zhao X, Wang X and Andersson R: Role of nuclear factor-kappaB, reactive oxygen species and cellular signaling in the early phase of acute pancreatitis. Scand J Gastroenterol. 40:103–108. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Xiao WQ, Yin GJ, Fan YT, et al: Catalpol ameliorates sodium taurocholate-induced acute pancreatitis in rats via inhibiting activation of nuclear factor kappa B. Int J Mol Sci. 15:11957–11972. 2014. View Article : Google Scholar : PubMed/NCBI

27 

He S, Wang L, Miao L, et al: Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 137:1100–1111. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Sarr MG: 2012 revision of the Atlanta classification of acute pancreatitis. Pol Arch Med Wewn. 123:118–124. 2013.PubMed/NCBI

29 

Jung KH, Hong SW, Zheng HM, et al: Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J Pineal Res. 48:239–250. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Talalay P, Dinkova-Kostova AT and Holtzclaw WD: Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul. 43:121–134. 2003. View Article : Google Scholar : PubMed/NCBI

31 

Sah RP and Saluja A: Molecular mechanisms of pancreatic injury. Curr Opin Gastroenterol. 27:444–451. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Chen X, Ji B, Han B, Ernst SA, Simeone D and Logsdon CD: NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology. 122:448–457. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Grady T, Liang P, Ernst SA and Logsdon CD: Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology. 113:1966–1975. 1997. View Article : Google Scholar : PubMed/NCBI

34 

Dabrowski A, Konturek SJ, Konturek JW and Gabryelewicz A: Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol. 377:1–11. 1999. View Article : Google Scholar : PubMed/NCBI

35 

Friedl HP, Till GO, Ryan US and Ward PA: Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 3:2512–2518. 1989.PubMed/NCBI

36 

Genovese T, Mazzon E, Di Paola R, et al: Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock. 25:161–167. 2006. View Article : Google Scholar : PubMed/NCBI

37 

Dinarello CA: Biologic basis for interleukin-1 in disease. Blood. 87:2095–2147. 1996.PubMed/NCBI

38 

Glasbrenner B and Adler G: Pathophysiology of acute pancreatitis. Hepatogastroenterology. 40:517–521. 1993.PubMed/NCBI

39 

Leindler L, Morschl E, László F, et al: Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats. Pancreas. 29:157–161. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Kuśnierz-Cabala B, Gurda-Duda A, Dumnicka P, et al: Analysis of selected inflammatory markers for early prediction of severe clinical course of acute pancreatitis. Przegl Lek. 70:392–396. 2013.(In Polish).

41 

Inagaki T, Hoshino M, Hayakawa T, et al: Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas. 14:1–8. 1997. View Article : Google Scholar : PubMed/NCBI

42 

Zhang XP, Zhang L, Chen LJ, et al: Influence of dexamethasone on inflammatory mediators and NF-kappaB expression in multiple organs of rats with severe acute pancreatitis. World J Gastroenterol. 13:548–556. 2007. View Article : Google Scholar : PubMed/NCBI

43 

Bae GS, Kim MS, Jeong J, et al: Piperine ameliorates the severity of cerulein-induced acute pancreatitis by inhibiting the activation of mitogen activated protein kinases. Biochem Biophys Res Commun. 410:382–388. 2011. View Article : Google Scholar : PubMed/NCBI

44 

Gui D, Huang J, Guo Y, et al: Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-kappaB-mediated inflammatory genes expression. Cytokine. 61:970–977. 2013. View Article : Google Scholar : PubMed/NCBI

45 

Meng Y, Ma QY, Kou XP and Xu J: Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis. World J Gastroenterol. 11:525–528. 2005. View Article : Google Scholar : PubMed/NCBI

46 

Treiber M, Neuhöfer P, Anetsberger E, et al: Myeloid, but not pancreatic, RelA/p65 is required for fibrosis in a mouse model of chronic pancreatitis. Gastroenterology. 141:1473–1485. 1485.e1471–1477. 2011. View Article : Google Scholar : PubMed/NCBI

47 

Hayden MS and Ghosh S: Signaling to NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI

48 

Barnes PJ: Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 94:557–572. 1998.

49 

Ethridge RT, Hashimoto K, Chung DH, Ehlers RA, Rajaraman S and Evers BM: Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis. J Am Coll Surg. 195:497–505. 2002. View Article : Google Scholar : PubMed/NCBI

50 

Mettu SR, Wig JD, Khullar M, Singh G and Gupta R: Efficacy of serum nitric oxide level estimation in assessing the severity of necrotizing pancreatitis. Pancreatology. 3:506–514. 2003. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qiu L, Yin G, Cheng L, Fan Y, Xiao W, Yu G, Xing M, Jia R, Sun R, Ma X, Ma X, et al: Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB. Int J Mol Med 35: 625-636, 2015.
APA
Qiu, L., Yin, G., Cheng, L., Fan, Y., Xiao, W., Yu, G. ... Zhao, Y. (2015). Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB. International Journal of Molecular Medicine, 35, 625-636. https://doi.org/10.3892/ijmm.2015.2070
MLA
Qiu, L., Yin, G., Cheng, L., Fan, Y., Xiao, W., Yu, G., Xing, M., Jia, R., Sun, R., Ma, X., Hu, G., Wang, X., Tang, M., Zhao, Y."Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB". International Journal of Molecular Medicine 35.3 (2015): 625-636.
Chicago
Qiu, L., Yin, G., Cheng, L., Fan, Y., Xiao, W., Yu, G., Xing, M., Jia, R., Sun, R., Ma, X., Hu, G., Wang, X., Tang, M., Zhao, Y."Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB". International Journal of Molecular Medicine 35, no. 3 (2015): 625-636. https://doi.org/10.3892/ijmm.2015.2070
Copy and paste a formatted citation
x
Spandidos Publications style
Qiu L, Yin G, Cheng L, Fan Y, Xiao W, Yu G, Xing M, Jia R, Sun R, Ma X, Ma X, et al: Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB. Int J Mol Med 35: 625-636, 2015.
APA
Qiu, L., Yin, G., Cheng, L., Fan, Y., Xiao, W., Yu, G. ... Zhao, Y. (2015). Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB. International Journal of Molecular Medicine, 35, 625-636. https://doi.org/10.3892/ijmm.2015.2070
MLA
Qiu, L., Yin, G., Cheng, L., Fan, Y., Xiao, W., Yu, G., Xing, M., Jia, R., Sun, R., Ma, X., Hu, G., Wang, X., Tang, M., Zhao, Y."Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB". International Journal of Molecular Medicine 35.3 (2015): 625-636.
Chicago
Qiu, L., Yin, G., Cheng, L., Fan, Y., Xiao, W., Yu, G., Xing, M., Jia, R., Sun, R., Ma, X., Hu, G., Wang, X., Tang, M., Zhao, Y."Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB". International Journal of Molecular Medicine 35, no. 3 (2015): 625-636. https://doi.org/10.3892/ijmm.2015.2070
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team